Favourable pharmacokinetics of intradermal adalimumab over subcutaneous administration: results of a randomized controlled trial
Justin Jacobse(Leiden University Medical Center), R. ten Cate(Leiden University), Anushka Tandon(Centre for Human Drug Research), Stefan Romeijn(Leiden University), Matthijs Moerland(Leiden University Medical Center), Gertjan Wolbink(Amsterdam UMC Location University of Amsterdam), Wim Jiskoot(Diagnostics for the Real World (United Kingdom)), Theo Rispens(Sanquin), Karien Bloem(Sanquin), Dirk Jan A. R. Moes(Leiden University Medical Center), Michiel J. van Esdonk(Centre for Human Drug Research), Annick de Vries(Sanquin), Joke A. Bouwstra(Centre for Human Drug Research), Hendrika W. Grievink(Centre for Human Drug Research), Lenneke Schrier(Leiden University Medical Center), Dimitrios Ziagkos(Centre for Human Drug Research), Jacobus Burggraaf(Leiden University), Wouter ten Voorde(Leiden University), Robert Rißmann(Leiden University), Floris C. Loeff(Sanquin), Marieke de Kam(Centre for Human Drug Research), Koen van der Maaden(Leiden University Medical Center)
Cited by 1
Related Papers
IgG Subclasses and Allotypes: From Structure to Effector Functions
|Frontiers in Immunology|2014|2.6k
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
|International Journal of Pharmaceutics|2021|1.5k
Extrinsic Fluorescent Dyes as Tools for Protein Characterization
|Pharmaceutical Research|2008|1.2k
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
|Nature Genetics|2008|542